Olivier Rixe
Hematology & Oncology · Albuquerque, NMNPI 1255568721
Payments from drug & device makers
Across 264 payments — averaging $6003.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$736K
- Daiichi Sankyo Inc.$647K
- Kyowa Kirin, Inc.$123K
- Kyowa Kirin Pharmaceutical Development, Inc$64K
- Amgen$6K
- AstraZeneca$6K
- plus $2K from 29 others
Across 1 payment — averaging $3200.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$3K
What the payments were for
- Food & beverage$1,48792%
- Education$1228%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 18 | $736,421 |
| Daiichi Sankyo Inc. | 11 | $647,021 |
| Kyowa Kirin, Inc. | 126 | $122,835 |
| Kyowa Kirin Pharmaceutical Development, Inc | 8 | $64,441 |
| Amgen | 6 | $6,234 |
| AstraZeneca | 11 | $5,912 |
| Regeneron | 1 | $859 |
| E.r. Squibb & Sons, L.L.C. | 19 | $284 |
| Seagen Inc. | 14 | $216 |
| Johnson & Johnson | 6 | $95 |
| Novartis | 6 | $87 |
| Puma Biotechnology, Inc. | 4 | $57 |
| Eisai Inc. | 3 | $56 |
| Novocure Inc. | 1 | $51 |
| Incyte Corporation | 3 | $49 |
| Rigel Pharmaceuticals, Inc. | 2 | $40 |
| Karyopharm Therapeutics Inc. | 2 | $38 |
| Gilead | 2 | $36 |
| Sanofi | 2 | $33 |
| Agios Pharmaceuticals, Inc. | 2 | $33 |
| Sanofi-aventis U.S. LLC | 1 | $29 |
| Lilly USA, LLC | 1 | $24 |
| Taiho Oncology, Inc. | 2 | $24 |
| Bayer | 2 | $24 |
| AbbVie | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Dendreon Pharmaceuticals LLC | 1 | $15 |
| EMD Serono, Inc. | 1 | $15 |
| Bristol Myers Squibb | 1 | $15 |
| Ipsen Biopharmaceuticals, Inc | 1 | $13 |
| Advanced Accelerator Applications | 1 | $12 |
| Exelixis Inc. | 1 | $12 |
| Acrotech Biopharma Inc. | 1 | $12 |
| AMAG Pharmaceuticals, Inc. | 1 | $11 |
| Clovis Oncology, Inc. | 1 | $7 |
How this compares
$1,585,052 in reported general payments places this provider in the 95th percentile of 54 hematology & oncology providers in New Mexico.
Other hematology & oncology in Albuquerque
- Ursa Brown GlabermanAlbuquerque$5M
- Neda Hashemi SadraeiAlbuquerque$1.6M
- Emrullah YilmazAlbuquerque$1.3M
- Erika MaestasAlbuquerque$880K
- Jose AvitiaAlbuquerque$553K
- Jacklyn NemunaitisAlbuquerque$351K
- Barbara McAnenyAlbuquerque$326K
- Zoneddy DayaoAlbuquerque$319K
- Yara AbdouAlbuquerque$294K
- Scott HerbertAlbuquerque$268K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.